Say Yes To Travel
Steve Sinclair appeared on “Say Yes to Travel” to discuss with host Sarah Dandashy an aspect of traveling that many people might not consider: lost and found. Everyone has had to deal with losing something somewhere at some point while on a trip, and Sinclair’s company, Bounte, helps reunite people with lost… well, bounty….
Latest
Hospitality
Why the Cruise Industry Requires a Unique Customer Service Model
The cruise industry was always a favorite for travelers, and it’s finally resurging after the pandemic. What does this new cruise experience look like, and what are guests now expecting? To answer this, Say Yes to Travel host Sarah Dandashy spoke with Paul Rutter. Rutter is a customer service expert, author, speaker, and spent 40…
Hospitality
A Historic Marina Reopens After A Major Renovation
On November 1, 2021, Palm Beach opened its newly renovated Town Marina. Say Yes to Travel host Sarah Dandashy chatted with Assistant Town Manager Carolyn Stone and dockmaster Mike Horn to explore this exciting project. The dock, originally from the 1940s, was at the end of its life. As the only public marina on the…
Hospitality
Coaching Hospitality Leaders to Develop Sustainable Energy
Driven by consumer desires for new experiences, innovative technologies and environmental impacts – travel is changing. Host Sarah Dandashy explores the technologies and logistics that power travel and the brands that build unforgettable experiences. Being a leader in any industry is challenging. It can be even more so in the hospitality sector because of the pressure…
Hospitality
For The Love of Travel Is Trying to Change How You Travel
The passion for travel can inspire more than just memories—it can also become a successful career. That’s the story of Tara Cappel, Founder and CEO of For the Love of (FTLO) Travel and Sojrn. She joined host Sarah Dandashy on Say Yes to Travel to talk about travel trends and her launch of Sojrn. “Travel has always been…
Hospitality
Adding Flexibility to an Archaic Real Estate Landscape
On this episode of Say Yes To Travel, Host Sarah Dandashy talked with Jason Fudin, Co-Founder and CEO of WhyHotel, a hospitality platform, and operator focusing on multifamily buildings. It operates pop-up hotels out of the vacancy of newly built luxury apartments during the initial lease-up process. They talked about Fudin’s career, his time…
Hospitality
Leadership in the Hospitality Space and Importance of a Social Media Community
Driven by consumer desires for new experiences, innovative technologies and environmental impacts – travel is changing. Host Sarah Dandashy explores the technologies and logistics that power travel and the brands that build unforgettable experiences. With so much change in the hospitality industry, many stakeholders are seeking new ideas, inspiration, and solving challenges. Hotel owner, operator and…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…